These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 11953150

  • 1. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
    Zheng S, Zhang J, Di X, Xiao Z, Wang D, Li C, He Z, Han N, Guo S, Cheng S, Gao Y.
    Zhonghua Yi Xue Za Zhi; 2002 Feb 10; 82(3):161-3. PubMed ID: 11953150
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
    van Tilborg AA, Groenfeld LE, van der Kwast TH, Zwarthoff EC.
    Br J Cancer; 1999 May 10; 80(3-4):489-94. PubMed ID: 10408858
    [Abstract] [Full Text] [Related]

  • 4. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
    Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA.
    Genes Chromosomes Cancer; 1999 Oct 10; 26(2):171-5. PubMed ID: 10469456
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.
    Edwards J, Duncan P, Going JJ, Watters AD, Grigor KM, Bartlett JM.
    J Pathol; 2002 Apr 10; 196(4):380-5. PubMed ID: 11920732
    [Abstract] [Full Text] [Related]

  • 10. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S, Poppe K, Fischer J, Nothnagel A, Estévez-Schwarz L, Haensch W, Schlag PM, Scherneck S.
    J Pathol; 2001 Jul 10; 194(3):318-26. PubMed ID: 11439364
    [Abstract] [Full Text] [Related]

  • 11. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R, Groussin L, Tissier F, Elie C, René-Corail F, Fratticci A, Jullian E, Beck-Peccoz P, Bertagna X, Gicquel C, Bertherat J.
    Clin Cancer Res; 2007 Feb 01; 13(3):844-50. PubMed ID: 17289876
    [Abstract] [Full Text] [Related]

  • 12. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder.
    Cappellen D, Gil Diez de Medina S, Chopin D, Thiery JP, Radvanyi F.
    Oncogene; 1997 Jun 26; 14(25):3059-66. PubMed ID: 9223669
    [Abstract] [Full Text] [Related]

  • 13. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
    Xiao Z, Zhang J, Zheng S, Li C, He Z, Cheng S, Gao Y.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 25; 82(20):1375-7. PubMed ID: 12509916
    [Abstract] [Full Text] [Related]

  • 14. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT, Fu L, Xia JC, Feng BJ, Mai SJ, Yu XJ, Huang LX, Feng QS, Pan ZZ, Zhan YQ.
    Ai Zheng; 2005 Nov 25; 24(11):1306-11. PubMed ID: 16552953
    [Abstract] [Full Text] [Related]

  • 15. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R, Utting M, Werner W, Schimmel B, Claussen U, Junker K.
    Int J Oncol; 2002 Jan 25; 20(1):107-15. PubMed ID: 11743649
    [Abstract] [Full Text] [Related]

  • 16. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.
    Takle LA, Knowles MA.
    Oncogene; 1996 Mar 07; 12(5):1083-7. PubMed ID: 8649800
    [Abstract] [Full Text] [Related]

  • 17. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
    Friedrich MG, Erbersdobler A, Schwaibold H, Conrad S, Huland E, Huland H.
    J Urol; 2000 Mar 07; 163(3):1039-42. PubMed ID: 10688045
    [Abstract] [Full Text] [Related]

  • 18. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF, Tang PZ, Cheng SJ.
    Ai Zheng; 2003 May 07; 22(5):452-7. PubMed ID: 12753701
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
    Edwards J, Duncan P, Going JJ, Grigor KM, Watters AD, Bartlett JM.
    Br J Cancer; 2001 Dec 14; 85(12):1894-9. PubMed ID: 11747332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.